MedTrace Logo

New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)

NCT01450969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2014-09-25

No results posted yet for this study

Summary

The PREFER Trial primary objective of the trial is to show how much radiation attenuation is provided by XPF in absolute and relative terms.

Conditions

  • Exposure

Sponsors & Collaborators

  • Baptist Health South Florida

    lead OTHER

Principal Investigators

  • Barry T. Katzen, MD · Baptist Hospital of Miami and its Miami Cardiac and Vascular Institute

  • Heiko Uthoff, MD · Baptist Hospital of Miami and its Miami Cardiac and Vascular Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01450969 on ClinicalTrials.gov